Drug class
Synthetic non-steroidal oestrogen; estrogen receptor agonist (historical agent)
Mechanism of action
Activates estrogen receptors and regulates oestrogen-responsive gene transcription. It is a potent synthetic oestrogen with historical prenatal exposure-related adverse effects and current use limited to specific exceptional indications.
General use cases
- Historical treatment of prostate cancer and selected breast cancer settings; use has been largely replaced by safer therapies. Prenatal exposure is associated with clear-cell adenocarcinoma and reproductive tract abnormalities in offspring, and it should not be presented as a routine contemporary oestrogen therapy.
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
